Clinical characteristics of patients
| Case | Age/Sex | Tumor Node Metastasis | Staging | Sphere Formation | No. of Cells Injected (Cell No.) | ||
|---|---|---|---|---|---|---|---|
| Parental | CD133− | CD133+ | |||||
| 1 | 56/M | T4aN0M0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (1/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (2/3) | |||||
| 2 | 52/F | T4bN1aM0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (1/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (3/3) | |||||
| 3 | 45/M | T4bN0M0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (1/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (1/3) | |||||
| 4 | 49/M | T4bN0M0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (0/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (2/3) | |||||
| 5 | 61/F | T4aN1bM0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (0/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (2/3) | |||||
| 6 | 42/M | T4bN0M0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (0/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (3/3) | |||||
| 7 | 51/M | T4aN0M0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (1/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (1/3) | |||||
| 8 | 65/M | T4bN0M0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (0/3) |
| 30,000 (0/3) | 30,000 (1/3) | 30,000 (2/3) | |||||
| 9 | 55/F | T4bN1aM0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (1/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (2/3) | |||||
| 10 | 71/F | T4aN0M0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (1/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (1/3) | |||||
| 11 | 78/M | T4aN1bM0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (1/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (2/3) | |||||
| 12 | 65/M | T4bN0M0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (0/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (2/3) | |||||
| 13 | 55/F | T4bN1aM0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (1/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (2/3) | |||||
| 14 | 75/F | T4aN0M0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (1/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (2/3) | |||||
| 15 | 82/M | T4aN1bM0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (1/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (2/3) | |||||
| 16 | 71/F | T4bN1aM0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (1/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (1/3) | |||||
| 17 | 56/M | T4bN0M0 | IV | Yes | 3000 (0/3) | 3000 (0/3) | 3000 (1/3) |
| 30,000 (0/3) | 30,000 (0/3) | 30,000 (2/3) | |||||
M, male; F, female.